References
- Berglund G., Sannerstedt R., Andersson O., Wedel H., Wilhelmsen L., Hansson L., Sivertsson R., Wikstrand J. Coronary heart disease after treatment of hypertension. Lancet 1978; 1: 1–51. Berglund G., Sannerstedt R., Andersson O., Wedel H., Wilhelmsen L., Hansson L., Sivertsson R., Wikstrand J. Coronary heart disease after treatment of hypertension. Lancet 1978; 1: 1–5
- Kannel W. B., Wolf P. A., Verter J., McNamara P. M. Epidemiological assessment of the role of blood pressure in stroke. J.A.M.A. 1970; 214: 301–3102. Kannel W. B., Wolf P. A., Verter J., McNamara P. M. Epidemiological assessment of the role of blood pressure in stroke. J.A.M.A. 1970; 214: 301–310
- Kellett R. J., Hamilton M. The treatment of benign hypertension with clonidine. Scott. Med. J. 1970; 15: 137–1423. Kellett R. J., Hamilton M. The treatment of benign hypertension with clonidine. Scott. Med. J. 1970; 15: 137–142
- Kobinger W., Walland A. Investigations into the mechanism of the hypotensive effect of 2-(2, 6-dichlorophenyl amino)-2-imidazoline hydrochloride. Eur. J. Pharmacol. 1967; 2: 155–1624. Kobinger W., Walland A. Investigations into the mechanism of the hypotensive effect of 2-(2, 6-dichlorophenyl amino)-2-imidazoline hydrochloride. Eur. J. Pharmacol. 1967; 2: 155–162
- Lawson A. A. H., Keston M. Clonidine in hypertension: a 6-year review. Curr. Med. Res. Opin. 1979; 6: 168–1745. Lawson A. A. H., Keston M. Clonidine in hypertension: a 6-year review. Curr. Med. Res. Opin. 1979; 6: 168–174
- Leahey W. J., Neill J. D., Varma M. P. S., Shanks R. G. Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol. Eur. J. Clin. Pharmacol. 1980; 17: 419–4246. Leahey W. J., Neill J. D., Varma M. P. S., Shanks R. G. Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol. Eur. J. Clin. Pharmacol. 1980; 17: 419–424
- Mroczek J. W., Leitch B. A., Finnerty F. A. Comparison of clonidine and methyldopa in hypertensive patients receiving a diuretic. Am. J. Cardiol. 1972; 29: 712–7177. Mroczek J. W., Leitch B. A., Finnerty F. A. Comparison of clonidine and methyldopa in hypertensive patients receiving a diuretic. Am. J. Cardiol. 1972; 29: 712–717
- Muir A. L., Burton J. L., Lawrie D. M. Circulatory effects at rest and exercise of clonidine, an imidazoline derivative with hypotensive properties. Lancet 1969; 2: 181–1858. Muir A. L., Burton J. L., Lawrie D. M. Circulatory effects at rest and exercise of clonidine, an imidazoline derivative with hypotensive properties. Lancet 1969; 2: 181–185
- Petrie J. C., Jeffers T. A., Robb O. J., Scott A. K., Webster J. Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension. Br. Med. J. 1980; 280: 1573–15749. Petrie J. C., Jeffers T. A., Robb O. J., Scott A. K., Webster J. Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension. Br. Med. J. 1980; 280: 1573–1574
- Putzeys M. R., Hoobler S. W. Comparison of clonidine and methyldopa on blood pressure and side-effects in hypertensive patients. Am. Heart J. 1972; 83: 464–46810. Putzeys M. R., Hoobler S. W. Comparison of clonidine and methyldopa on blood pressure and side-effects in hypertensive patients. Am. Heart J. 1972; 83: 464–468
- Raftos J., Bauer G. E., Lewis R. G., Stokes C. S., Mitchell A. S., Young A. A., MacLachlan I. Clonidine in the treatment of severe hypertension. Med. J. Aust. 1973; 1: 786–79311. Raftos J., Bauer G. E., Lewis R. G., Stokes C. S., Mitchell A. S., Young A. A., MacLachlan I. Clonidine in the treatment of severe hypertension. Med. J. Aust. 1973; 1: 786–793
- Steger W. Treatment of hypertensive out-patients with Catapres sustained release perlongets. Therapiewoche 1979; 29: 5202–520612. Steger W. Treatment of hypertensive out-patients with Catapres sustained release perlongets. Therapiewoche 1979; 29: 5202–5206
- Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114mmHg. J.A.M.A. 1970; 213: 1143–115213. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114mmHg. J.A.M.A. 1970; 213: 1143–1152
- Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. III. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects. Circulation 1972; 45: 991–100414. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. III. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects. Circulation 1972; 45: 991–1004
- Whitsett T. L., Chrysant S. G., Dilland B. L., Anton A. H. Abrupt cessation of clonidine administration: a prospective study. Am. J. Cardiol. 1978; 41: 1285–129015. Whitsett T. L., Chrysant S. G., Dilland B. L., Anton A. H. Abrupt cessation of clonidine administration: a prospective study. Am. J. Cardiol. 1978; 41: 1285–1290
- Wilkinson P. R., Raftery E. B. A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension. Br. J. Clin. Pharmacol. 1977; 4: 289–29416. Wilkinson P. R., Raftery E. B. A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension. Br. J. Clin. Pharmacol. 1977; 4: 289–294